Cited by 124Cancer, Hypoxia, and MetabolismMechanisms of cancer metastasisAngiogenesis and VEGF in Cancer

The role of hypoxia-inducible factor-2 in digestive system cancers

Open access
Zhao, J, Du, F, Shen, G, Zheng, F, Xu, B·2015·Cell Death & Disease

Abstract

Hypoxia is an all but ubiquitous phenomenon in cancers. Two known hypoxia-inducible factors (HIFs), HIF-1 α and HIF-2 α , primarily mediate the transcriptional response to hypoxia. Despite the high homology between HIF-1 α and HIF-2 α , emerging evidence suggests differences between both molecules in terms of transcriptional targets as well as impact on multiple physiological pathways and tumorigenesis. To date, much progress has been made toward understanding the roles of HIF-2 α in digestive system cancers. Indeed, HIF-2 α has been shown to regulate multiple aspects of digestive system cancers, including cell proliferation, angiogenesis and apoptosis, metabolism, metastasis and resistance to chemotherapy. These findings make HIF-2 α a critical regulator of this malignant phenotype. Here we summarize the function of HIF-2 during cancer development as well as its contribution to tumorigenesis in digestive system malignancies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/cddis.2014.565

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • EPO is often considered a prototypical HIF-2 target, although regulation by all three HIF isoforms has also been reported.

    “Erythropoietin (EPO) is often considered a prototypical HIF-2 target [65,100], although regulation by all three HIF isoforms has also been reported [101]”

    From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [65]

  • HIF-2α is an important transcription factor in cancer progression and leads to poor prognosis.

    “Given that HIF-2α is an important transcription factor in cancer progression and leads to poor prognosis69,70”

    From Glutamine reliance in cell metabolism (2020) · cites this paper as [69]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

2 retracted

Flagged first, then by citations

1 of the 111 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Zhao, J., Du, F., Shen, G., Zheng, F., & Xu, B.
Affiliations
  • Qinghai University (CN)
  • Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Corresponding author
Xu, B
Venue
Cell Death & Disease
Published
2015-01-15
Volume
6
Issue
1
Pages
e1600-e1600
ISSN
2041-4889 (ISSN-L)
OpenAlex
W2039630990
Cited by
122
References
111
Citations by year
2026: 5 · 2025: 3 · 2024: 16 · 2023: 6 · 2022: 11 · 2021: 9 · 2020: 17 · 2019: 12 · 2018: 15 · 2017: 9 · 2016: 11 · 2015: 8
FWCI
1.39
Type
journal article
Language
en
Open access
Locations
  • Cell Death and Disease (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China (81360318)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords
HIF-2α, HIF-2, gastrointestinal cancer, tumor hypoxia, carcinogenesis, angiogenesis, cell proliferation, apoptosis, cancer metabolism, metastasis, chemoresistance
MeSH terms
Endothelial PAS Domain-Containing Protein 1, Animals, Digestive System Neoplasms, Humans, Neovascularization, Pathologic, Drug Resistance, Neoplasm, Cell Proliferation, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review